Zolmitriptane as Prophylaxis for Chilhood Migraine

Tanta University

Status and phase: Enrolling; Phase 4

Conditions: Migraine

Treatments: Drug: Valproate; Drug: zolmitriptanee; Drug: topiramate

Study type: Interventional

Funder types: Other

Identifiers

NCT06089356

Migraine

Details and patient eligibility

About

zolmitriptane can be tried as prophylactic therapy of childhood migraine

Full description

90 children with migraine included in the study first group 30 received zolmitriptane second group 30 received topiramate third group 30 received valproate

Enrollment: 90 estimated patients

Sex: All

Ages: 8 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

children with migraine -

Exclusion criteria

those who suffer from ischemic heart disease , or who have allergy to any of drugs used

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

90 participants in 3 patient groups

zolmitriptane

Active Comparator group

Description:

zolmitriptane tablet daily

Treatment:

Drug: zolmitriptanee

topiramate

Active Comparator group

Description:

topiramate tablet daily

Treatment:

Drug: topiramate

valproate

Active Comparator group

Description:

valproate once daily

Treatment:

Drug: Valproate